# Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease

> **NCT06528522** · — · NOT_YET_RECRUITING · sponsor: **Necmettin Erbakan University** · enrollment: 100 (estimated)

## Conditions studied

- Periodontitis, Adult
- Smoking
- Periodontal Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Clinical Measurements and Saliva Sample Collection

## Key facts

- **NCT ID:** NCT06528522
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528522, "Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06528522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*